Intellihealth
Intellihealth is an obesity medicine telehealth platform built primarily for health systems, employers, and payers rather than individual consumers. Founded in 2019, the company's core model is B2B2C: they partner with health systems and large employers to deliver board-certified obesity medicine care at scale, integrating with existing healthcare infrastructure rather than operating as a standalone consumer app. Patients who access Intellihealth through a health system partnership often have th
Overview
- Consultation Model
- Hybrid
- Headquarters
- Philadelphia, PA
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility.
- Founded
- 2019
Pros
- Board-certified obesity medicine physicians
- Integration with health systems means care is documented in the patient's main medical record
- Evidence-based obesity medicine protocols rather than symptom-and-prescription transactional model
- Institutional backing provides clinical oversight and accountability often absent from DTC platforms
- Better positioned to manage complex patients with multiple comorbidities
- Treats obesity as a chronic disease requiring ongoing management, not a one-time prescription event
Cons
- Difficult or impossible to access without an employer or health system partnership
- Not designed for patients seeking fast, self-directed access to GLP-1 medications
- Geographic availability limited by institutional partnerships rather than physician licensure alone
- Less consumer-friendly onboarding compared to DTC telehealth platforms
- Pricing transparency is poor for individual consumers trying to evaluate options
- Not suitable for patients whose employers haven't contracted with Intellihealth